McKesson Corp
F:MCK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
McKesson Corp
F:MCK
|
US |
|
V
|
VeriSign, Inc
XMUN:VRS
|
US |
Intrinsic Value
The intrinsic value of 
McKesson Corp (MCK) under the Base Case is 1 026.9 EUR per share.
Compared with the current market price of 911.4 EUR, the stock appears
Undervalued by 11% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What McKesson Does
McKesson is a healthcare supply chain company. It buys prescription drugs, medical products, and related services from manufacturers and delivers them to pharmacies, hospitals, doctor offices, and other care providers. It also helps customers manage inventory, ordering, and day-to-day distribution work that keeps medicines and supplies moving through the healthcare system.
- Headquarters
- United States of America US
- Employees
- 43 000
- IPO date
- Nov 10, 1994
McKesson has a narrow economic moat
Buying medicines in bulk and spreading warehouse and delivery costs across a large customer base make it difficult for smaller distributors to match McKesson’s prices. Its software also makes some pharmacy customers harder to win away because replacing it means changing daily work and retraining staff, although Cencora and Cardinal Health remain strong alternatives.
Read the full moat analysis
Revenue & Expenses Breakdown
McKesson Corp
Earnings Waterfall
McKesson Corp
The intrinsic value for McKesson Corp (MCK) under the Base Case is 1 026.9 EUR.
Compared with the current market price of 911.4 EUR, the stock appears Undervalued by 11% .